COIN-B shows cetuximab can be safely added to two intermittent chemotherapy strategies for advanced colorectal cancer
Latest News
95 years of research for the MRC
95 years of research for the MRC
Trials using biomarkers to assign patients to treatment for bowel cancer
Trials using biomarkers to assign patients to treatment for bowel cancer are feasible in a UK multi-centre setting
ARROW trial wins BMJ UK Research Paper of the Year award
ARROW trial wins BMJ UK Research Paper of the Year award